nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP2C8—Bupropion—obesity	0.04	0.0758	CbGbCtD
Lansoprazole—CYP1A2—Phentermine—obesity	0.0365	0.069	CbGbCtD
Lansoprazole—CYP1A2—Phenylpropanolamine—obesity	0.0348	0.0659	CbGbCtD
Lansoprazole—CYP2C9—Phentermine—obesity	0.0329	0.0622	CbGbCtD
Lansoprazole—CYP1A2—Bupropion—obesity	0.031	0.0587	CbGbCtD
Lansoprazole—CYP2D6—Phentermine—obesity	0.03	0.0569	CbGbCtD
Lansoprazole—CYP2C8—Cimetidine—obesity	0.0294	0.0557	CbGbCtD
Lansoprazole—CYP2C9—Bupropion—obesity	0.0279	0.0529	CbGbCtD
Lansoprazole—CYP2D6—Bupropion—obesity	0.0255	0.0484	CbGbCtD
Lansoprazole—CYP3A4—Sibutramine—obesity	0.0252	0.0477	CbGbCtD
Lansoprazole—CYP2C19—Cimetidine—obesity	0.0247	0.0467	CbGbCtD
Lansoprazole—CYP2D6—Methamphetamine—obesity	0.024	0.0455	CbGbCtD
Lansoprazole—CYP1A2—Cimetidine—obesity	0.0228	0.0431	CbGbCtD
Lansoprazole—CYP2C9—Cimetidine—obesity	0.0205	0.0388	CbGbCtD
Lansoprazole—ABCB1—Cimetidine—obesity	0.0199	0.0377	CbGbCtD
Lansoprazole—CYP3A4—Benzphetamine—obesity	0.0191	0.0362	CbGbCtD
Lansoprazole—CYP2D6—Cimetidine—obesity	0.0187	0.0355	CbGbCtD
Lansoprazole—CYP3A4—Bupropion—obesity	0.0162	0.0308	CbGbCtD
Lansoprazole—CYP2C19—Topiramate—obesity	0.0161	0.0306	CbGbCtD
Lansoprazole—CYP3A4—Orlistat—obesity	0.0132	0.0251	CbGbCtD
Lansoprazole—CYP3A4—Cimetidine—obesity	0.0119	0.0226	CbGbCtD
Lansoprazole—CYP3A4—Topiramate—obesity	0.0078	0.0148	CbGbCtD
Lansoprazole—ATP4B—digestive system—obesity	0.00328	0.063	CbGeAlD
Lansoprazole—ATP4B—endocrine gland—obesity	0.00271	0.052	CbGeAlD
Lansoprazole—ATP4B—liver—obesity	0.00245	0.0469	CbGeAlD
Lansoprazole—ATP4A—respiratory system—obesity	0.00225	0.0431	CbGeAlD
Lansoprazole—MAPT—pituitary gland—obesity	0.00205	0.0394	CbGeAlD
Lansoprazole—MAPT—adipose tissue—obesity	0.00204	0.0392	CbGeAlD
Lansoprazole—ATP4A—adrenal cortex—obesity	0.00189	0.0362	CbGeAlD
Lansoprazole—MAPT—adrenal gland—obesity	0.00183	0.0352	CbGeAlD
Lansoprazole—CYP4A11—digestive system—obesity	0.00177	0.034	CbGeAlD
Lansoprazole—ATP4A—cardiovascular system—obesity	0.00172	0.033	CbGeAlD
Lansoprazole—CYP4A11—endocrine gland—obesity	0.00146	0.0281	CbGeAlD
Lansoprazole—ATP4A—digestive system—obesity	0.00143	0.0274	CbGeAlD
Lansoprazole—ATP4A—adrenal gland—obesity	0.00136	0.0261	CbGeAlD
Lansoprazole—CYP4A11—liver—obesity	0.00132	0.0253	CbGeAlD
Lansoprazole—ATP4A—endocrine gland—obesity	0.00118	0.0227	CbGeAlD
Lansoprazole—CYP2C18—digestive system—obesity	0.00117	0.0225	CbGeAlD
Lansoprazole—ATP4A—liver—obesity	0.00106	0.0204	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—obesity	0.00097	0.0186	CbGeAlD
Lansoprazole—CYP1B1—respiratory system—obesity	0.000895	0.0172	CbGeAlD
Lansoprazole—CYP2C18—liver—obesity	0.000875	0.0168	CbGeAlD
Lansoprazole—CYP2D6—hindbrain—obesity	0.000748	0.0143	CbGeAlD
Lansoprazole—CYP1B1—cardiovascular system—obesity	0.000685	0.0131	CbGeAlD
Lansoprazole—CYP1A2—respiratory system—obesity	0.000641	0.0123	CbGeAlD
Lansoprazole—CYP1A1—respiratory system—obesity	0.000633	0.0121	CbGeAlD
Lansoprazole—CYP1B1—pituitary gland—obesity	0.000607	0.0116	CbGeAlD
Lansoprazole—CYP1B1—adipose tissue—obesity	0.000604	0.0116	CbGeAlD
Lansoprazole—CYP1B1—digestive system—obesity	0.000569	0.0109	CbGeAlD
Lansoprazole—ABCG2—adrenal cortex—obesity	0.000559	0.0107	CbGeAlD
Lansoprazole—CYP1B1—adrenal gland—obesity	0.000542	0.0104	CbGeAlD
Lansoprazole—CYP2C19—digestive system—obesity	0.000499	0.00958	CbGeAlD
Lansoprazole—CYP1B1—endocrine gland—obesity	0.00047	0.00902	CbGeAlD
Lansoprazole—CYP2C9—cardiovascular system—obesity	0.000466	0.00894	CbGeAlD
Lansoprazole—CYP2C8—pituitary gland—obesity	0.000465	0.00891	CbGeAlD
Lansoprazole—ABCG2—pituitary gland—obesity	0.000452	0.00867	CbGeAlD
Lansoprazole—ABCG2—adipose tissue—obesity	0.00045	0.00863	CbGeAlD
Lansoprazole—CYP1A1—adipose tissue—obesity	0.000427	0.0082	CbGeAlD
Lansoprazole—CYP1B1—liver—obesity	0.000424	0.00813	CbGeAlD
Lansoprazole—CYP2C19—endocrine gland—obesity	0.000412	0.00791	CbGeAlD
Lansoprazole—CYP1A2—digestive system—obesity	0.000408	0.00782	CbGeAlD
Lansoprazole—ABCG2—adrenal gland—obesity	0.000404	0.00774	CbGeAlD
Lansoprazole—CYP1A1—digestive system—obesity	0.000402	0.00771	CbGeAlD
Lansoprazole—CYP2C9—digestive system—obesity	0.000387	0.00742	CbGeAlD
Lansoprazole—CYP2C19—liver—obesity	0.000372	0.00713	CbGeAlD
Lansoprazole—CYP2C8—endocrine gland—obesity	0.00036	0.00691	CbGeAlD
Lansoprazole—ABCB1—islet of Langerhans—obesity	0.000348	0.00667	CbGeAlD
Lansoprazole—CYP1A2—endocrine gland—obesity	0.000337	0.00646	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—obesity	0.000332	0.00637	CbGeAlD
Lansoprazole—ABCB1—respiratory system—obesity	0.000329	0.0063	CbGeAlD
Lansoprazole—CYP2C8—liver—obesity	0.000325	0.00623	CbGeAlD
Lansoprazole—CYP2C9—endocrine gland—obesity	0.00032	0.00613	CbGeAlD
Lansoprazole—ABCG2—liver—obesity	0.000316	0.00605	CbGeAlD
Lansoprazole—CYP1A2—liver—obesity	0.000304	0.00583	CbGeAlD
Lansoprazole—CYP1A1—liver—obesity	0.0003	0.00575	CbGeAlD
Lansoprazole—CYP3A4—digestive system—obesity	0.000295	0.00566	CbGeAlD
Lansoprazole—CYP2D6—digestive system—obesity	0.00029	0.00557	CbGeAlD
Lansoprazole—CYP2C9—liver—obesity	0.000288	0.00553	CbGeAlD
Lansoprazole—ABCB1—adrenal cortex—obesity	0.000276	0.00529	CbGeAlD
Lansoprazole—ABCB1—cardiovascular system—obesity	0.000252	0.00483	CbGeAlD
Lansoprazole—CYP3A4—endocrine gland—obesity	0.000244	0.00468	CbGeAlD
Lansoprazole—CYP2D6—endocrine gland—obesity	0.00024	0.0046	CbGeAlD
Lansoprazole—ABCB1—pituitary gland—obesity	0.000223	0.00427	CbGeAlD
Lansoprazole—ABCB1—adipose tissue—obesity	0.000222	0.00426	CbGeAlD
Lansoprazole—CYP3A4—liver—obesity	0.00022	0.00422	CbGeAlD
Lansoprazole—CYP2D6—liver—obesity	0.000216	0.00415	CbGeAlD
Lansoprazole—ABCB1—digestive system—obesity	0.000209	0.00401	CbGeAlD
Lansoprazole—ABCB1—adrenal gland—obesity	0.000199	0.00382	CbGeAlD
Lansoprazole—ABCB1—endocrine gland—obesity	0.000173	0.00331	CbGeAlD
Lansoprazole—ABCB1—liver—obesity	0.000156	0.00299	CbGeAlD
Lansoprazole—Hypokalaemia—Topiramate—obesity	0.000121	0.000463	CcSEcCtD
Lansoprazole—Muscle spasms—Bupropion—obesity	0.000121	0.000462	CcSEcCtD
Lansoprazole—Infection—Orlistat—obesity	0.000121	0.000462	CcSEcCtD
Lansoprazole—Breast disorder—Topiramate—obesity	0.00012	0.000459	CcSEcCtD
Lansoprazole—Dry mouth—Sibutramine—obesity	0.00012	0.000459	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Topiramate—obesity	0.00012	0.000458	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Topiramate—obesity	0.00012	0.000458	CcSEcCtD
Lansoprazole—Nervous system disorder—Orlistat—obesity	0.000119	0.000456	CcSEcCtD
Lansoprazole—Nasopharyngitis—Topiramate—obesity	0.000119	0.000454	CcSEcCtD
Lansoprazole—Confusional state—Sibutramine—obesity	0.000118	0.000453	CcSEcCtD
Lansoprazole—Vision blurred—Bupropion—obesity	0.000118	0.000453	CcSEcCtD
Lansoprazole—Skin disorder—Orlistat—obesity	0.000118	0.000451	CcSEcCtD
Lansoprazole—Tremor—Bupropion—obesity	0.000118	0.00045	CcSEcCtD
Lansoprazole—Gastritis—Topiramate—obesity	0.000118	0.00045	CcSEcCtD
Lansoprazole—Anaphylactic shock—Sibutramine—obesity	0.000117	0.00045	CcSEcCtD
Lansoprazole—Oedema—Sibutramine—obesity	0.000117	0.00045	CcSEcCtD
Lansoprazole—Hyperhidrosis—Orlistat—obesity	0.000117	0.000449	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Topiramate—obesity	0.000117	0.000448	CcSEcCtD
Lansoprazole—Muscular weakness—Topiramate—obesity	0.000117	0.000448	CcSEcCtD
Lansoprazole—Infection—Sibutramine—obesity	0.000117	0.000447	CcSEcCtD
Lansoprazole—Ill-defined disorder—Bupropion—obesity	0.000116	0.000446	CcSEcCtD
Lansoprazole—Anaemia—Bupropion—obesity	0.000116	0.000444	CcSEcCtD
Lansoprazole—Shock—Sibutramine—obesity	0.000116	0.000442	CcSEcCtD
Lansoprazole—Abdominal distension—Topiramate—obesity	0.000116	0.000442	CcSEcCtD
Lansoprazole—Agitation—Bupropion—obesity	0.000115	0.000441	CcSEcCtD
Lansoprazole—Thrombocytopenia—Sibutramine—obesity	0.000115	0.00044	CcSEcCtD
Lansoprazole—Asthma—Topiramate—obesity	0.000115	0.000439	CcSEcCtD
Lansoprazole—Dysphagia—Topiramate—obesity	0.000115	0.000439	CcSEcCtD
Lansoprazole—Angioedema—Bupropion—obesity	0.000115	0.000439	CcSEcCtD
Lansoprazole—Tachycardia—Sibutramine—obesity	0.000115	0.000439	CcSEcCtD
Lansoprazole—Skin disorder—Sibutramine—obesity	0.000114	0.000437	CcSEcCtD
Lansoprazole—Eosinophilia—Topiramate—obesity	0.000114	0.000435	CcSEcCtD
Lansoprazole—Hyperhidrosis—Sibutramine—obesity	0.000114	0.000435	CcSEcCtD
Lansoprazole—Malaise—Bupropion—obesity	0.000113	0.000433	CcSEcCtD
Lansoprazole—Vertigo—Bupropion—obesity	0.000113	0.000432	CcSEcCtD
Lansoprazole—Syncope—Bupropion—obesity	0.000113	0.000431	CcSEcCtD
Lansoprazole—Pancreatitis—Topiramate—obesity	0.000113	0.000431	CcSEcCtD
Lansoprazole—Leukopenia—Bupropion—obesity	0.000112	0.00043	CcSEcCtD
Lansoprazole—Anorexia—Sibutramine—obesity	0.000112	0.000429	CcSEcCtD
Lansoprazole—Angina pectoris—Topiramate—obesity	0.000112	0.000428	CcSEcCtD
Lansoprazole—Palpitations—Bupropion—obesity	0.000111	0.000425	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Orlistat—obesity	0.000111	0.000423	CcSEcCtD
Lansoprazole—Bronchitis—Topiramate—obesity	0.00011	0.000422	CcSEcCtD
Lansoprazole—Loss of consciousness—Bupropion—obesity	0.00011	0.000422	CcSEcCtD
Lansoprazole—Abdominal discomfort—Topiramate—obesity	0.00011	0.000421	CcSEcCtD
Lansoprazole—Insomnia—Orlistat—obesity	0.00011	0.00042	CcSEcCtD
Lansoprazole—Hypotension—Sibutramine—obesity	0.00011	0.00042	CcSEcCtD
Lansoprazole—Cough—Bupropion—obesity	0.00011	0.000419	CcSEcCtD
Lansoprazole—Paraesthesia—Orlistat—obesity	0.000109	0.000417	CcSEcCtD
Lansoprazole—Pancytopenia—Topiramate—obesity	0.000109	0.000417	CcSEcCtD
Lansoprazole—Convulsion—Bupropion—obesity	0.000109	0.000416	CcSEcCtD
Lansoprazole—Hypertension—Bupropion—obesity	0.000108	0.000415	CcSEcCtD
Lansoprazole—Dysuria—Topiramate—obesity	0.000107	0.000411	CcSEcCtD
Lansoprazole—Neutropenia—Topiramate—obesity	0.000107	0.000411	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Sibutramine—obesity	0.000107	0.00041	CcSEcCtD
Lansoprazole—Dyspepsia—Orlistat—obesity	0.000107	0.000409	CcSEcCtD
Lansoprazole—Myalgia—Bupropion—obesity	0.000107	0.000409	CcSEcCtD
Lansoprazole—Arthralgia—Bupropion—obesity	0.000107	0.000409	CcSEcCtD
Lansoprazole—Chest pain—Bupropion—obesity	0.000107	0.000409	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Topiramate—obesity	0.000107	0.000408	CcSEcCtD
Lansoprazole—Anxiety—Bupropion—obesity	0.000106	0.000408	CcSEcCtD
Lansoprazole—Insomnia—Sibutramine—obesity	0.000106	0.000407	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000106	0.000406	CcSEcCtD
Lansoprazole—Pollakiuria—Topiramate—obesity	0.000106	0.000406	CcSEcCtD
Lansoprazole—Erectile dysfunction—Topiramate—obesity	0.000106	0.000405	CcSEcCtD
Lansoprazole—Discomfort—Bupropion—obesity	0.000106	0.000404	CcSEcCtD
Lansoprazole—Decreased appetite—Orlistat—obesity	0.000106	0.000404	CcSEcCtD
Lansoprazole—Paraesthesia—Sibutramine—obesity	0.000106	0.000404	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Orlistat—obesity	0.000105	0.000401	CcSEcCtD
Lansoprazole—Dyspnoea—Sibutramine—obesity	0.000105	0.000401	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Topiramate—obesity	0.000105	0.000401	CcSEcCtD
Lansoprazole—Fatigue—Orlistat—obesity	0.000105	0.000401	CcSEcCtD
Lansoprazole—Dry mouth—Bupropion—obesity	0.000104	0.0004	CcSEcCtD
Lansoprazole—Somnolence—Sibutramine—obesity	0.000104	0.0004	CcSEcCtD
Lansoprazole—Weight increased—Topiramate—obesity	0.000104	0.0004	CcSEcCtD
Lansoprazole—Pain—Orlistat—obesity	0.000104	0.000397	CcSEcCtD
Lansoprazole—Hyperglycaemia—Topiramate—obesity	0.000104	0.000396	CcSEcCtD
Lansoprazole—Dyspepsia—Sibutramine—obesity	0.000103	0.000396	CcSEcCtD
Lansoprazole—Confusional state—Bupropion—obesity	0.000103	0.000395	CcSEcCtD
Lansoprazole—Pneumonia—Topiramate—obesity	0.000103	0.000394	CcSEcCtD
Lansoprazole—Oedema—Bupropion—obesity	0.000102	0.000392	CcSEcCtD
Lansoprazole—Anaphylactic shock—Bupropion—obesity	0.000102	0.000392	CcSEcCtD
Lansoprazole—Infestation NOS—Topiramate—obesity	0.000102	0.000392	CcSEcCtD
Lansoprazole—Infestation—Topiramate—obesity	0.000102	0.000392	CcSEcCtD
Lansoprazole—Decreased appetite—Sibutramine—obesity	0.000102	0.000391	CcSEcCtD
Lansoprazole—Infection—Bupropion—obesity	0.000102	0.00039	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Topiramate—obesity	0.000101	0.000388	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Sibutramine—obesity	0.000101	0.000388	CcSEcCtD
Lansoprazole—Shock—Bupropion—obesity	0.000101	0.000386	CcSEcCtD
Lansoprazole—Renal failure—Topiramate—obesity	0.000101	0.000385	CcSEcCtD
Lansoprazole—Pain—Sibutramine—obesity	0.0001	0.000385	CcSEcCtD
Lansoprazole—Constipation—Sibutramine—obesity	0.0001	0.000385	CcSEcCtD
Lansoprazole—Nervous system disorder—Bupropion—obesity	0.0001	0.000384	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Topiramate—obesity	0.0001	0.000384	CcSEcCtD
Lansoprazole—Thrombocytopenia—Bupropion—obesity	0.0001	0.000384	CcSEcCtD
Lansoprazole—Feeling abnormal—Orlistat—obesity	0.0001	0.000383	CcSEcCtD
Lansoprazole—Tachycardia—Bupropion—obesity	0.0001	0.000383	CcSEcCtD
Lansoprazole—Stomatitis—Topiramate—obesity	9.97e-05	0.000382	CcSEcCtD
Lansoprazole—Skin disorder—Bupropion—obesity	9.95e-05	0.000381	CcSEcCtD
Lansoprazole—Conjunctivitis—Topiramate—obesity	9.95e-05	0.000381	CcSEcCtD
Lansoprazole—Urinary tract infection—Topiramate—obesity	9.95e-05	0.000381	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Orlistat—obesity	9.93e-05	0.00038	CcSEcCtD
Lansoprazole—Hyperhidrosis—Bupropion—obesity	9.9e-05	0.000379	CcSEcCtD
Lansoprazole—Anorexia—Bupropion—obesity	9.76e-05	0.000374	CcSEcCtD
Lansoprazole—Haematuria—Topiramate—obesity	9.76e-05	0.000373	CcSEcCtD
Lansoprazole—Feeling abnormal—Sibutramine—obesity	9.68e-05	0.000371	CcSEcCtD
Lansoprazole—Epistaxis—Topiramate—obesity	9.65e-05	0.000369	CcSEcCtD
Lansoprazole—Urticaria—Orlistat—obesity	9.64e-05	0.000369	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Sibutramine—obesity	9.61e-05	0.000368	CcSEcCtD
Lansoprazole—Sinusitis—Topiramate—obesity	9.6e-05	0.000367	CcSEcCtD
Lansoprazole—Abdominal pain—Orlistat—obesity	9.6e-05	0.000367	CcSEcCtD
Lansoprazole—Body temperature increased—Orlistat—obesity	9.6e-05	0.000367	CcSEcCtD
Lansoprazole—Hypotension—Bupropion—obesity	9.57e-05	0.000366	CcSEcCtD
Lansoprazole—Agranulocytosis—Topiramate—obesity	9.55e-05	0.000365	CcSEcCtD
Lansoprazole—Bradycardia—Topiramate—obesity	9.35e-05	0.000358	CcSEcCtD
Lansoprazole—Urticaria—Sibutramine—obesity	9.33e-05	0.000357	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Bupropion—obesity	9.33e-05	0.000357	CcSEcCtD
Lansoprazole—Abdominal pain—Sibutramine—obesity	9.29e-05	0.000356	CcSEcCtD
Lansoprazole—Body temperature increased—Sibutramine—obesity	9.29e-05	0.000356	CcSEcCtD
Lansoprazole—Insomnia—Bupropion—obesity	9.26e-05	0.000355	CcSEcCtD
Lansoprazole—Rhinitis—Topiramate—obesity	9.21e-05	0.000352	CcSEcCtD
Lansoprazole—Paraesthesia—Bupropion—obesity	9.2e-05	0.000352	CcSEcCtD
Lansoprazole—Hepatitis—Topiramate—obesity	9.19e-05	0.000352	CcSEcCtD
Lansoprazole—Hallucination—Topiramate—obesity	9.14e-05	0.00035	CcSEcCtD
Lansoprazole—Hypoaesthesia—Topiramate—obesity	9.14e-05	0.00035	CcSEcCtD
Lansoprazole—Dyspnoea—Bupropion—obesity	9.13e-05	0.00035	CcSEcCtD
Lansoprazole—Pharyngitis—Topiramate—obesity	9.12e-05	0.000349	CcSEcCtD
Lansoprazole—Somnolence—Bupropion—obesity	9.11e-05	0.000349	CcSEcCtD
Lansoprazole—Urinary tract disorder—Topiramate—obesity	9.07e-05	0.000347	CcSEcCtD
Lansoprazole—Oedema peripheral—Topiramate—obesity	9.05e-05	0.000346	CcSEcCtD
Lansoprazole—Connective tissue disorder—Topiramate—obesity	9.03e-05	0.000346	CcSEcCtD
Lansoprazole—Dyspepsia—Bupropion—obesity	9.02e-05	0.000345	CcSEcCtD
Lansoprazole—Urethral disorder—Topiramate—obesity	9e-05	0.000345	CcSEcCtD
Lansoprazole—Hypersensitivity—Orlistat—obesity	8.94e-05	0.000342	CcSEcCtD
Lansoprazole—Decreased appetite—Bupropion—obesity	8.9e-05	0.000341	CcSEcCtD
Lansoprazole—Visual impairment—Topiramate—obesity	8.85e-05	0.000339	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Bupropion—obesity	8.84e-05	0.000338	CcSEcCtD
Lansoprazole—Fatigue—Bupropion—obesity	8.83e-05	0.000338	CcSEcCtD
Lansoprazole—Pain—Bupropion—obesity	8.76e-05	0.000335	CcSEcCtD
Lansoprazole—Constipation—Bupropion—obesity	8.76e-05	0.000335	CcSEcCtD
Lansoprazole—Asthenia—Orlistat—obesity	8.71e-05	0.000333	CcSEcCtD
Lansoprazole—Erythema multiforme—Topiramate—obesity	8.68e-05	0.000332	CcSEcCtD
Lansoprazole—Hypersensitivity—Sibutramine—obesity	8.66e-05	0.000331	CcSEcCtD
Lansoprazole—Pruritus—Orlistat—obesity	8.59e-05	0.000329	CcSEcCtD
Lansoprazole—Eye disorder—Topiramate—obesity	8.58e-05	0.000329	CcSEcCtD
Lansoprazole—Tinnitus—Topiramate—obesity	8.56e-05	0.000328	CcSEcCtD
Lansoprazole—Cardiac disorder—Topiramate—obesity	8.52e-05	0.000326	CcSEcCtD
Lansoprazole—Feeling abnormal—Bupropion—obesity	8.44e-05	0.000323	CcSEcCtD
Lansoprazole—Asthenia—Sibutramine—obesity	8.43e-05	0.000323	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Bupropion—obesity	8.38e-05	0.000321	CcSEcCtD
Lansoprazole—Angiopathy—Topiramate—obesity	8.33e-05	0.000319	CcSEcCtD
Lansoprazole—Pruritus—Sibutramine—obesity	8.31e-05	0.000318	CcSEcCtD
Lansoprazole—Diarrhoea—Orlistat—obesity	8.31e-05	0.000318	CcSEcCtD
Lansoprazole—Immune system disorder—Topiramate—obesity	8.3e-05	0.000318	CcSEcCtD
Lansoprazole—Mediastinal disorder—Topiramate—obesity	8.28e-05	0.000317	CcSEcCtD
Lansoprazole—Chills—Topiramate—obesity	8.24e-05	0.000315	CcSEcCtD
Lansoprazole—Urticaria—Bupropion—obesity	8.14e-05	0.000311	CcSEcCtD
Lansoprazole—Alopecia—Topiramate—obesity	8.12e-05	0.000311	CcSEcCtD
Lansoprazole—Abdominal pain—Bupropion—obesity	8.1e-05	0.00031	CcSEcCtD
Lansoprazole—Body temperature increased—Bupropion—obesity	8.1e-05	0.00031	CcSEcCtD
Lansoprazole—Mental disorder—Topiramate—obesity	8.05e-05	0.000308	CcSEcCtD
Lansoprazole—Diarrhoea—Sibutramine—obesity	8.04e-05	0.000308	CcSEcCtD
Lansoprazole—Dizziness—Orlistat—obesity	8.03e-05	0.000307	CcSEcCtD
Lansoprazole—Malnutrition—Topiramate—obesity	8e-05	0.000306	CcSEcCtD
Lansoprazole—Erythema—Topiramate—obesity	8e-05	0.000306	CcSEcCtD
Lansoprazole—Flatulence—Topiramate—obesity	7.88e-05	0.000302	CcSEcCtD
Lansoprazole—Tension—Topiramate—obesity	7.85e-05	0.0003	CcSEcCtD
Lansoprazole—Dysgeusia—Topiramate—obesity	7.83e-05	0.0003	CcSEcCtD
Lansoprazole—Dizziness—Sibutramine—obesity	7.77e-05	0.000297	CcSEcCtD
Lansoprazole—Nervousness—Topiramate—obesity	7.77e-05	0.000297	CcSEcCtD
Lansoprazole—Back pain—Topiramate—obesity	7.73e-05	0.000296	CcSEcCtD
Lansoprazole—Vomiting—Orlistat—obesity	7.72e-05	0.000295	CcSEcCtD
Lansoprazole—Muscle spasms—Topiramate—obesity	7.69e-05	0.000294	CcSEcCtD
Lansoprazole—Rash—Orlistat—obesity	7.65e-05	0.000293	CcSEcCtD
Lansoprazole—Dermatitis—Orlistat—obesity	7.65e-05	0.000293	CcSEcCtD
Lansoprazole—Headache—Orlistat—obesity	7.61e-05	0.000291	CcSEcCtD
Lansoprazole—Hypersensitivity—Bupropion—obesity	7.55e-05	0.000289	CcSEcCtD
Lansoprazole—Vision blurred—Topiramate—obesity	7.54e-05	0.000288	CcSEcCtD
Lansoprazole—Tremor—Topiramate—obesity	7.49e-05	0.000287	CcSEcCtD
Lansoprazole—Vomiting—Sibutramine—obesity	7.47e-05	0.000286	CcSEcCtD
Lansoprazole—Ill-defined disorder—Topiramate—obesity	7.42e-05	0.000284	CcSEcCtD
Lansoprazole—Rash—Sibutramine—obesity	7.41e-05	0.000284	CcSEcCtD
Lansoprazole—Dermatitis—Sibutramine—obesity	7.4e-05	0.000283	CcSEcCtD
Lansoprazole—Anaemia—Topiramate—obesity	7.39e-05	0.000283	CcSEcCtD
Lansoprazole—Headache—Sibutramine—obesity	7.36e-05	0.000282	CcSEcCtD
Lansoprazole—Asthenia—Bupropion—obesity	7.35e-05	0.000281	CcSEcCtD
Lansoprazole—Agitation—Topiramate—obesity	7.35e-05	0.000281	CcSEcCtD
Lansoprazole—Pruritus—Bupropion—obesity	7.25e-05	0.000277	CcSEcCtD
Lansoprazole—Nausea—Orlistat—obesity	7.21e-05	0.000276	CcSEcCtD
Lansoprazole—Malaise—Topiramate—obesity	7.21e-05	0.000276	CcSEcCtD
Lansoprazole—Vertigo—Topiramate—obesity	7.18e-05	0.000275	CcSEcCtD
Lansoprazole—Syncope—Topiramate—obesity	7.17e-05	0.000274	CcSEcCtD
Lansoprazole—Leukopenia—Topiramate—obesity	7.16e-05	0.000274	CcSEcCtD
Lansoprazole—Palpitations—Topiramate—obesity	7.07e-05	0.00027	CcSEcCtD
Lansoprazole—Loss of consciousness—Topiramate—obesity	7.03e-05	0.000269	CcSEcCtD
Lansoprazole—Diarrhoea—Bupropion—obesity	7.01e-05	0.000268	CcSEcCtD
Lansoprazole—Nausea—Sibutramine—obesity	6.98e-05	0.000267	CcSEcCtD
Lansoprazole—Cough—Topiramate—obesity	6.98e-05	0.000267	CcSEcCtD
Lansoprazole—Convulsion—Topiramate—obesity	6.93e-05	0.000265	CcSEcCtD
Lansoprazole—Hypertension—Topiramate—obesity	6.9e-05	0.000264	CcSEcCtD
Lansoprazole—Arthralgia—Topiramate—obesity	6.81e-05	0.000261	CcSEcCtD
Lansoprazole—Myalgia—Topiramate—obesity	6.81e-05	0.000261	CcSEcCtD
Lansoprazole—Chest pain—Topiramate—obesity	6.81e-05	0.000261	CcSEcCtD
Lansoprazole—Anxiety—Topiramate—obesity	6.78e-05	0.00026	CcSEcCtD
Lansoprazole—Dizziness—Bupropion—obesity	6.77e-05	0.000259	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.76e-05	0.000259	CcSEcCtD
Lansoprazole—Discomfort—Topiramate—obesity	6.73e-05	0.000257	CcSEcCtD
Lansoprazole—Dry mouth—Topiramate—obesity	6.66e-05	0.000255	CcSEcCtD
Lansoprazole—Confusional state—Topiramate—obesity	6.58e-05	0.000252	CcSEcCtD
Lansoprazole—Oedema—Topiramate—obesity	6.53e-05	0.00025	CcSEcCtD
Lansoprazole—Vomiting—Bupropion—obesity	6.51e-05	0.000249	CcSEcCtD
Lansoprazole—Infection—Topiramate—obesity	6.48e-05	0.000248	CcSEcCtD
Lansoprazole—Rash—Bupropion—obesity	6.46e-05	0.000247	CcSEcCtD
Lansoprazole—Dermatitis—Bupropion—obesity	6.45e-05	0.000247	CcSEcCtD
Lansoprazole—Shock—Topiramate—obesity	6.42e-05	0.000246	CcSEcCtD
Lansoprazole—Headache—Bupropion—obesity	6.42e-05	0.000246	CcSEcCtD
Lansoprazole—Nervous system disorder—Topiramate—obesity	6.4e-05	0.000245	CcSEcCtD
Lansoprazole—Thrombocytopenia—Topiramate—obesity	6.39e-05	0.000245	CcSEcCtD
Lansoprazole—Tachycardia—Topiramate—obesity	6.37e-05	0.000244	CcSEcCtD
Lansoprazole—Skin disorder—Topiramate—obesity	6.34e-05	0.000243	CcSEcCtD
Lansoprazole—Hyperhidrosis—Topiramate—obesity	6.31e-05	0.000241	CcSEcCtD
Lansoprazole—Anorexia—Topiramate—obesity	6.22e-05	0.000238	CcSEcCtD
Lansoprazole—Hypotension—Topiramate—obesity	6.1e-05	0.000233	CcSEcCtD
Lansoprazole—Nausea—Bupropion—obesity	6.08e-05	0.000233	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Topiramate—obesity	5.95e-05	0.000228	CcSEcCtD
Lansoprazole—Insomnia—Topiramate—obesity	5.9e-05	0.000226	CcSEcCtD
Lansoprazole—Paraesthesia—Topiramate—obesity	5.86e-05	0.000224	CcSEcCtD
Lansoprazole—Dyspnoea—Topiramate—obesity	5.82e-05	0.000223	CcSEcCtD
Lansoprazole—Somnolence—Topiramate—obesity	5.8e-05	0.000222	CcSEcCtD
Lansoprazole—Dyspepsia—Topiramate—obesity	5.74e-05	0.00022	CcSEcCtD
Lansoprazole—Decreased appetite—Topiramate—obesity	5.67e-05	0.000217	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Topiramate—obesity	5.63e-05	0.000216	CcSEcCtD
Lansoprazole—Fatigue—Topiramate—obesity	5.63e-05	0.000215	CcSEcCtD
Lansoprazole—Pain—Topiramate—obesity	5.58e-05	0.000214	CcSEcCtD
Lansoprazole—Constipation—Topiramate—obesity	5.58e-05	0.000214	CcSEcCtD
Lansoprazole—Feeling abnormal—Topiramate—obesity	5.38e-05	0.000206	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Topiramate—obesity	5.34e-05	0.000204	CcSEcCtD
Lansoprazole—Urticaria—Topiramate—obesity	5.18e-05	0.000198	CcSEcCtD
Lansoprazole—Abdominal pain—Topiramate—obesity	5.16e-05	0.000197	CcSEcCtD
Lansoprazole—Body temperature increased—Topiramate—obesity	5.16e-05	0.000197	CcSEcCtD
Lansoprazole—Hypersensitivity—Topiramate—obesity	4.81e-05	0.000184	CcSEcCtD
Lansoprazole—Asthenia—Topiramate—obesity	4.68e-05	0.000179	CcSEcCtD
Lansoprazole—Pruritus—Topiramate—obesity	4.62e-05	0.000177	CcSEcCtD
Lansoprazole—Diarrhoea—Topiramate—obesity	4.47e-05	0.000171	CcSEcCtD
Lansoprazole—Dizziness—Topiramate—obesity	4.32e-05	0.000165	CcSEcCtD
Lansoprazole—Vomiting—Topiramate—obesity	4.15e-05	0.000159	CcSEcCtD
Lansoprazole—Rash—Topiramate—obesity	4.11e-05	0.000157	CcSEcCtD
Lansoprazole—Dermatitis—Topiramate—obesity	4.11e-05	0.000157	CcSEcCtD
Lansoprazole—Headache—Topiramate—obesity	4.09e-05	0.000156	CcSEcCtD
Lansoprazole—Nausea—Topiramate—obesity	3.88e-05	0.000148	CcSEcCtD
Lansoprazole—CYP2C9—Metabolism—STK11—obesity	3.6e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FASN—obesity	3.59e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—obesity	3.58e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—obesity	3.58e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—COMT—obesity	3.58e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—BCHE—obesity	3.58e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARA—obesity	3.56e-06	2.24e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNB3—obesity	3.53e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARGC1A—obesity	3.53e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNAS—obesity	3.52e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—obesity	3.52e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—obesity	3.51e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2E1—obesity	3.45e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOB—obesity	3.45e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRKAR2B—obesity	3.45e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CB—obesity	3.45e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—obesity	3.44e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNAS—obesity	3.44e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DCN—obesity	3.42e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—obesity	3.42e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NQO1—obesity	3.41e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—COMT—obesity	3.37e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—obesity	3.37e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOB—obesity	3.37e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—COMT—obesity	3.35e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—obesity	3.34e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.34e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—obesity	3.34e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CPT1A—obesity	3.33e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARGC1A—obesity	3.33e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNB3—obesity	3.33e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—obesity	3.32e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—obesity	3.31e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.31e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNB3—obesity	3.3e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARGC1A—obesity	3.3e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—obesity	3.29e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—obesity	3.28e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCG—obesity	3.27e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A4—obesity	3.27e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—obesity	3.27e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARA—obesity	3.26e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LIPC—obesity	3.25e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCK—obesity	3.25e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNAS—obesity	3.24e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYCS—obesity	3.23e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOC3—obesity	3.23e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—obesity	3.22e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—obesity	3.21e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNAS—obesity	3.21e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.19e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOB—obesity	3.17e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGT1—obesity	3.17e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT1—obesity	3.17e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—obesity	3.16e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOB—obesity	3.15e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—obesity	3.14e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—obesity	3.13e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CETP—obesity	3.13e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—obesity	3.13e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOA1—obesity	3.12e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SDC1—obesity	3.1e-06	1.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—obesity	3.09e-06	1.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—STK11—obesity	3.08e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP19A1—obesity	3.08e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—obesity	3.06e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—obesity	3.06e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—obesity	3.05e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C3—obesity	3.05e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—obesity	3.05e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—obesity	3.03e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—obesity	3e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SCARB1—obesity	3e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—obesity	2.97e-06	1.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—obesity	2.96e-06	1.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—obesity	2.94e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—obesity	2.93e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.93e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—obesity	2.93e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SREBF1—obesity	2.91e-06	1.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARA—obesity	2.91e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—obesity	2.9e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—obesity	2.89e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—obesity	2.88e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—obesity	2.88e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—COMT—obesity	2.86e-06	1.8e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—obesity	2.85e-06	1.8e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARA—obesity	2.84e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT2—obesity	2.83e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNB3—obesity	2.82e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARGC1A—obesity	2.82e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—obesity	2.82e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—obesity	2.81e-06	1.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—obesity	2.79e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FASN—obesity	2.77e-06	1.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—obesity	2.76e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BCHE—obesity	2.76e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—obesity	2.75e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNAS—obesity	2.74e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—obesity	2.74e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—obesity	2.73e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—obesity	2.73e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—obesity	2.7e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—obesity	2.7e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—obesity	2.69e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOB—obesity	2.69e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CD—obesity	2.68e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARA—obesity	2.68e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—obesity	2.67e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—obesity	2.66e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2E1—obesity	2.66e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—obesity	2.66e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARA—obesity	2.65e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—obesity	2.64e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—obesity	2.64e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NQO1—obesity	2.63e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.61e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—obesity	2.59e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—obesity	2.57e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—obesity	2.57e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—obesity	2.56e-06	1.61e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—obesity	2.54e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—obesity	2.53e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3R1—obesity	2.53e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCG—obesity	2.52e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A4—obesity	2.52e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—obesity	2.52e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—obesity	2.52e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—obesity	2.51e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—obesity	2.5e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—obesity	2.49e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—obesity	2.49e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYCS—obesity	2.49e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—obesity	2.49e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CD—obesity	2.45e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGT1—obesity	2.44e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT1—obesity	2.44e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—obesity	2.44e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—obesity	2.43e-06	1.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—obesity	2.42e-06	1.53e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOA1—obesity	2.41e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—obesity	2.41e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.38e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STK11—obesity	2.37e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP19A1—obesity	2.37e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—obesity	2.37e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—obesity	2.36e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—obesity	2.35e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CB—obesity	2.33e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3R1—obesity	2.32e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—obesity	2.32e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—obesity	2.32e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—obesity	2.31e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—obesity	2.31e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—obesity	2.31e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—obesity	2.3e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—obesity	2.29e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—obesity	2.27e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARA—obesity	2.27e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—obesity	2.21e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—COMT—obesity	2.21e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—obesity	2.2e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—obesity	2.19e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CD—obesity	2.19e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—obesity	2.18e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARGC1A—obesity	2.18e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNB3—obesity	2.18e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—obesity	2.17e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—obesity	2.17e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—obesity	2.16e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—obesity	2.16e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—obesity	2.15e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—obesity	2.15e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CB—obesity	2.14e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CD—obesity	2.14e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—obesity	2.13e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—obesity	2.13e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—obesity	2.12e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNAS—obesity	2.12e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—obesity	2.11e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—obesity	2.1e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOB—obesity	2.07e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3R1—obesity	2.07e-06	1.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—obesity	2.07e-06	1.3e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.04e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3R1—obesity	2.02e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—obesity	2.02e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CD—obesity	2.01e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CD—obesity	2e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—obesity	1.99e-06	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—obesity	1.98e-06	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—obesity	1.97e-06	1.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—obesity	1.94e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—obesity	1.93e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CB—obesity	1.91e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3R1—obesity	1.9e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—obesity	1.9e-06	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—obesity	1.89e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—obesity	1.89e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3R1—obesity	1.89e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—obesity	1.89e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—obesity	1.88e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—obesity	1.87e-06	1.18e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CB—obesity	1.86e-06	1.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—obesity	1.85e-06	1.17e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—obesity	1.85e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—obesity	1.84e-06	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—obesity	1.78e-06	1.12e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CB—obesity	1.76e-06	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARA—obesity	1.75e-06	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CB—obesity	1.74e-06	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—obesity	1.74e-06	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—obesity	1.73e-06	1.09e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—obesity	1.72e-06	1.08e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CD—obesity	1.71e-06	1.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—obesity	1.69e-06	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—obesity	1.69e-06	1.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—obesity	1.66e-06	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—obesity	1.65e-06	1.04e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—obesity	1.64e-06	1.04e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—obesity	1.61e-06	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3R1—obesity	1.61e-06	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—obesity	1.5e-06	9.45e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CB—obesity	1.49e-06	9.38e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—obesity	1.47e-06	9.3e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—obesity	1.45e-06	9.12e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—obesity	1.43e-06	8.99e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—obesity	1.42e-06	8.97e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—obesity	1.42e-06	8.94e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CD—obesity	1.32e-06	8.31e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—obesity	1.3e-06	8.22e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—obesity	1.3e-06	8.2e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3R1—obesity	1.24e-06	7.84e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—obesity	1.24e-06	7.84e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—obesity	1.16e-06	7.34e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—obesity	1.16e-06	7.33e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CB—obesity	1.15e-06	7.24e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—obesity	1.14e-06	7.17e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—obesity	1.14e-06	7.16e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—obesity	1.07e-06	6.75e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—obesity	1.07e-06	6.72e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—obesity	1.06e-06	6.69e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—obesity	9.51e-07	6e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—obesity	9.28e-07	5.85e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—obesity	9.07e-07	5.72e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—obesity	8.75e-07	5.52e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—obesity	8.67e-07	5.47e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—obesity	7.41e-07	4.67e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—obesity	7e-07	4.41e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—obesity	5.72e-07	3.61e-06	CbGpPWpGaD
